Lumeris and MIT Partner to Enhance AI-Driven Primary Care
Lumeris has announced a strategic partnership with the MIT Computational Biology Lab to advance its AI-driven platform, Tom, which delivers Primary Care as a Service. Announced in a press release, the collaboration aims to integrate advanced computational models to improve understanding and guidance of individual and population health interventions.
The MIT Computational Biology Lab, led by Professor Manolis Kellis, is renowned for its expertise in using AI and data science to explore health and disease mechanisms. This partnership will leverage the lab's analytical techniques alongside Tom's proactive services and Lumeris' clinical workflow knowledge to enhance personalized and scalable primary care.
Tom, Lumeris' AI-powered platform, is embedded in primary care workflows to autonomously execute actions such as patient check-ins, scheduling screenings, and monitoring medications. The integration of dynamic modeling techniques from MIT will enable Tom to better anticipate future health events and deliver timely interventions, addressing the primary care gap affecting millions of Americans.
We hope you enjoyed this article.
Consider subscribing to one of several newsletters we publish like Life AI Weekly.
Also, consider following us on social media:
More from: Healthcare & Life Sciences
Divamics' AI Platform Advances Metabolic Disease Drug Discovery
Omega Healthcare Expands AI Solutions with Microsoft Collaboration
Viome and Scripps Research Develop At-Home RNA Test for Colon Cancer Prevention
Jackson Laboratory and NYSCF Form Alliance for Biomedical Research
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read more